FDA requests withdrawal of weight-loss drug Belviq, Belviq XR
Feb 13 - Increased occurrence of cancer seen in large clinical trial
Drugs
The Center for Drug Evaluation and Research (CDER) ensures that safe and effective drugs are available to improve the health of the people in the United States
Topic Paragraphs
Clinical trial diversity supports new drug approvals
Snapshots include demographic breakdown and subgroup differences
Learn MoreFeatures
Resources for You
Consumers and Patients
Find drug information. Report drug side effects. Learn how to buy, use, and dispose of unused drugs. Attend a public meeting.
Health Care Professionals
Get drug safety, recall, and shortage information. Report drug adverse events. Find jobs at FDA. Watch training/education videos and courses.
Industry
Search drug databases. Find guidance, submission, user fee, and meeting information. Get small business assistance. Find jobs at FDA.
Drug Safety Announcements
Center
Drug-related Recall Announcements
Feb 20
Taro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall of Phenytoin Oral Suspension USP, 125 mg/5ml Due to Possible Underdosing or Overdosing
Jan 31
Efficient Laboratories, Inc. Issues Voluntary Nationwide Recall of Rompe Pecho EX, Rompe Pecho CF, and Rompe Pecho MAX due to Microbial Contamination
Jan 31
Salud Natural Entrepreneur Inc. Recalls Nopalina Flax Seed Fiber Powder and Nopalina Flax Seed Fiber Capsules Because of Possible Health Risk (Updated Lot Number Information)
Center
CENTER FOR DRUG EVALUATION AND RESEARCH
Office of Communications
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993
Toll Free
(855) 543-3784
(301) 796-3400
Hours Available
CDER Division of Drug Information
Paragraph Header (Column 2)
FOR UPDATES ON TWITTER FOLLOW
Paragraph Header (Column 2)
FOR UPDATES ON TWITTER FOLLOW
@FDA_Drug_Info
Your source for the latest drug information.
Know the moment it happens.